SARS-CoV-2 is not unique in its ability to cause post-acute sequelae; certain acute
infections have long been associated with an unexplained chronic disability in a minority of …

In late 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) triggered the
global coronavirus disease 2019 (COVID-19) pandemic. Although most infections cause a …

Seven years after the declaration of the first epidemic of Ebola virus disease in Guinea, the
country faced a new outbreak—between 14 February and 19 June 2021—near the …

The male genital tract (MGT) is the target of a number of viral infections that can have
deleterious consequences at the individual, offspring, and population levels. These …

Background Sexual transmission chains of Ebola virus (EBOV) have been verified and
linked to EBOV RNA persistence in semen, post-recovery. The rate of semen persistence …

This report summarizes the recommendations of the Advisory Committee on Immunization
Practices (ACIP) for use of the rVSVΔG-ZEBOV-GP Ebola vaccine (Ervebo) in the United …

There is an increasing frequency of reports regarding the persistence of the Ebola virus
(EBOV) in Ebola virus disease (EVD) survivors. During the 2014–2016 West African EVD …

The illness ME/CFS has been repeatedly tied to infectious agents such as Epstein Barr
Virus. Expanding research on the human microbiome now allows ME/CFS-associated …

Introduction The 21st century has seen a series of viral pandemics that have collectively
infected millions of individuals. To understand factors that may contribute to viral spread and …

Ebola virus (EBOV) can persist in immunologically protected body sites in survivors of Ebola
virus disease, creating the potential to initiate new chains of transmission. From the outbreak …